- Filed
- Mar 27, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 2.57B sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 2.55B sh |
| Shares Diluted | FY 2025 · Dec 31, 2023 | 2.53B sh |
| Capex | FY 2025 · Dec 31, 2025 | $374.48M |
| Capex | FY 2025 · Dec 31, 2025 | ¥2.62B |
| Capex | FY 2025 · Dec 31, 2024 | ¥2.3B |
| Capex | FY 2025 · Dec 31, 2023 | ¥2.75B |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $869.37M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | ¥6.09B |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | ¥4.23B |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | ¥2.9B |
| Short Term Investments | FY 2025 · Dec 31, 2025 | $368.1M |
| Short Term Investments | FY 2025 · Dec 31, 2025 | ¥2.58B |
| Short Term Investments | FY 2025 · Dec 31, 2024 | ¥250M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $327.44M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | ¥2.29B |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | ¥4.36B |
| Cash And Equivalents | FY 2025 · Dec 31, 2023 | ¥2.93B |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $2.23B |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | ¥15.62B |
| Stockholders Equity restated | FY 2025 · Dec 31, 2024 | ¥11.56B |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $1.21B |
| Current Liabilities | FY 2025 · Dec 31, 2025 | ¥8.51B |
| Current Liabilities restated | FY 2025 · Dec 31, 2024 | ¥6.69B |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $1.88B |
| Total Liabilities | FY 2025 · Dec 31, 2025 | ¥13.16B |
| Total Liabilities restated | FY 2025 · Dec 31, 2024 | ¥10.05B |
| Current Assets | FY 2025 · Dec 31, 2025 | $2.06B |
| Current Assets | FY 2025 · Dec 31, 2025 | ¥14.43B |
| Current Assets restated | FY 2025 · Dec 31, 2024 | ¥10.73B |
| Total Assets | FY 2025 · Dec 31, 2025 | $4.32B |
| Total Assets | FY 2025 · Dec 31, 2025 | ¥30.3B |
| Total Assets restated | FY 2025 · Dec 31, 2024 | ¥23.13B |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $0.20 |
| Eps Diluted | FY 2025 · Dec 31, 2025 | ¥1.40 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | ¥1.16 |
| Eps Diluted | FY 2025 · Dec 31, 2023 | ¥1.12 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $0.20 |
| Eps Basic | FY 2025 · Dec 31, 2025 | ¥1.40 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | ¥1.16 |
| Eps Basic | FY 2025 · Dec 31, 2023 | ¥1.12 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $436.32M |
| Sga Expense | FY 2025 · Dec 31, 2025 | ¥3.06B |
| Sga Expense | FY 2025 · Dec 31, 2024 | ¥2.42B |
| Sga Expense | FY 2025 · Dec 31, 2023 | ¥1.83B |
| Net Income | FY 2025 · Dec 31, 2025 | $513.88M |
| Net Income | FY 2025 · Dec 31, 2025 | ¥3.6B |
| Net Income restated | FY 2025 · Dec 31, 2024 | ¥2.96B |
| Net Income restated | FY 2025 · Dec 31, 2023 | ¥2.84B |
| Operating Income | FY 2025 · Dec 31, 2025 | $724.05M |
| Operating Income | FY 2025 · Dec 31, 2025 | ¥5.07B |
| Operating Income restated | FY 2025 · Dec 31, 2024 | ¥3.57B |
| Operating Income restated | FY 2025 · Dec 31, 2023 | ¥3.02B |
| Revenue | FY 2025 · Dec 31, 2025 | $7.03B |
| Revenue | FY 2025 · Dec 31, 2025 | ¥49.29B |
| Revenue | FY 2025 · Dec 31, 2024 | ¥34.47B |
| Revenue | FY 2025 · Dec 31, 2023 | ¥24.9B |